NYSE:MRK - New York Stock Exchange, Inc. - US58933Y1055 - Common Stock - Currency: USD
81.71
-0.11 (-0.13%)
The current stock price of MRK is 81.71 USD. In the past month the price increased by 11.37%. In the past year, price decreased by -36.81%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 59.55 | 776.54B | ||
JNJ | JOHNSON & JOHNSON | 15.63 | 377.99B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 21.87 | 354.71B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 14.37 | 235.92B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 16.91 | 230.73B | ||
PFE | PFIZER INC | 7.64 | 139.52B | ||
SNY | SANOFI-ADR | 10.99 | 120.88B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 6.78 | 101.25B | ||
GSK | GSK PLC-SPON ADR | 9.14 | 82.81B | ||
ZTS | ZOETIS INC | 27.3 | 73.16B | ||
HLN | HALEON PLC-ADR | 21.74 | 48.91B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 63.33 | 47.48B |
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. The firm's segments include Pharmaceutical and Animal Health. Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells its human health vaccines primarily to physicians, wholesalers, distributors and government entities. Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. The company sells its products to veterinarians, distributors, animal producers, farmers and pet owners.
MERCK & CO. INC.
126 East Lincoln Avenue, P.O. Box 2000
Rahway NEW JERSEY 07033 US
CEO: Kenneth C. Frazier
Employees: 74000
Phone: 19087404000
The current stock price of MRK is 81.71 USD. The price decreased by -0.13% in the last trading session.
The exchange symbol of MERCK & CO. INC. is MRK and it is listed on the New York Stock Exchange, Inc. exchange.
MRK stock is listed on the New York Stock Exchange, Inc. exchange.
32 analysts have analysed MRK and the average price target is 104.83 USD. This implies a price increase of 28.3% is expected in the next year compared to the current price of 81.71. Check the MERCK & CO. INC. stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MERCK & CO. INC. (MRK) has a market capitalization of 205.18B USD. This makes MRK a Mega Cap stock.
MERCK & CO. INC. (MRK) currently has 74000 employees.
MERCK & CO. INC. (MRK) has a support level at 81.81 and a resistance level at 81.83. Check the full technical report for a detailed analysis of MRK support and resistance levels.
The Revenue of MERCK & CO. INC. (MRK) is expected to grow by 1.67% in the next year. Check the estimates tab for more information on the MRK EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MERCK & CO. INC. (MRK) has a dividend yield of 4.17%. The yearly dividend amount is currently 3.1. Check the full fundamental report for a detailed analysis of MRK dividend history, reliability and sustainability.
MERCK & CO. INC. (MRK) will report earnings on 2025-07-29, before the market open.
The PE ratio for MERCK & CO. INC. (MRK) is 10.49. This is based on the reported non-GAAP earnings per share of 7.79 and the current share price of 81.71 USD. Check the full fundamental report for a full analysis of the valuation metrics for MRK.
The outstanding short interest for MERCK & CO. INC. (MRK) is 1.64% of its float. Check the ownership tab for more information on the MRK short interest.
ChartMill assigns a technical rating of 2 / 10 to MRK. When comparing the yearly performance of all stocks, MRK is a bad performer in the overall market: 88.92% of all stocks are doing better.
ChartMill assigns a fundamental rating of 8 / 10 to MRK. Both the health and profitability get an excellent rating, making MRK a very profitable company, without any liquidiy or solvency issues.
Over the last trailing twelve months MRK reported a non-GAAP Earnings per Share(EPS) of 7.79. The EPS increased by 258.99% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 27.27% | ||
ROA | 15.14% | ||
ROE | 36.07% | ||
Debt/Equity | 0.69 |
ChartMill assigns a Buy % Consensus number of 77% to MRK. The Buy consensus is the average rating of analysts ratings from 32 analysts.
For the next year, analysts expect an EPS growth of 17.73% and a revenue growth 1.67% for MRK